Pathophysiology of Respiratory Distress Syndrome and Surfactant Metabolism

Fetal and Neonatal Physiology: Third Edition

Volumn 2-2, Issue , 2003, Pages 1055-1068

  Jobe, Alan H ^a,b   Ikegami, Machiko ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33947144433     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-9654-6.50107-7     Document Type: Chapter

References (84)

1. Avery ME, Mead J Surface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child 1959, 97:517.
2. Jobe AH Pulmonary surfactant therapy. N Engl J Med 1993, 328:861.
3. Langston C, et al. Human lung growth in late gestation and in the neonate. Am Rev Respir Dis 1984, 129:607.
4. Hislop AA, et al. Alveolar development in the human fetus and infant. Early Hum Dev 1986, 13:1.
5. Burri PH Structural aspects of prenatal and postnatal development and growth of the lung. Lung Growth and Development 1997, 1. Marcel Dekker, New York. J.A. McDonald (Ed.).
6. Bunton TE, Plopper CG Triamcinolone-induced structural alterations in the development of the lung of the fetal rhesus macaque. Am J Obstet Gynecol 1984, 148:203.
7. Massaro DJ, Massaro GD The regulation of the formation of pulmonary alveoli. Chronic Lung Disease in Early Infancy 2000, Vol 137:479. Marcel Dekker, New York. R.D. Bland, J.J. Coalson (Eds.).
8. Wright JR, Dobbs LG Regulation of pulmonary surfactant secretion and clearance. Annu Rev Physiol 1991, 53:395.
9. McCormack FX Structure, processing and properties of surfactant protein A. Biochim Biophys Acta 1998, 1408:109.
10. Schurch S, et al. Formation and structure of surface films: captive bubble surfactometry. Biochim Biophys Acta 1998, 1408:180.
11. Gurel O, et al. Macrophage and type II cell catabolism of SP-A and saturated phosphatidylcholine in mouse lung. Am J Physiol 2001, 280:L1266.
12. Jacobs HC, et al. Reutilization of surfactant phosphatidylcholine in adult rabbits. Biochim Biophys Acta 1985, 837:77.
13. Ueda T, et al. Clearance of surfactant protein A from rabbit lungs. Am J Respir Cell Mol Biol 1995, 12:89.
14. Ueda T, et al. Clearance of surfactant protein B from rabbit lungs. Am J Physiol 1995, 268:L636.
15. Ikegami M, et al. Clearance of SP-C and recombinant SP-C in vivo and in vitro. Am J Physiol 1998, 274:L933.
16. Ueda T, et al. Developmental changes of sheep surfactant: in vivo function and in vitro subtype conversion. J Appl Physiol 1994, 76:2701.
17. Hallman M, et al. Phosphatidylinositol and phosphatidylglycerol in amniotic fluid: indices of lung maturity. Am J Obstet Gynecol 1976, 125:613.
18. Kulovich MV, et al. The lung profile: normal pregnancy. Am J Obstet Gynecol 1979, 135:57.
19. Obladen M Alterations in surfactant composition. Bronchopulmonary Dysplasia 1988, Vol 4:131. Blackwell Scientific, Boston. T.A. Merritt (Ed.).
20. Pryhuber GS, et al. Ontogeny of surfactant protein-A and protein-B in human amniotic fluid as indices of fetal lung maturity. Pediatr Res 1991, 30:597.
21. Bachurski CJ, et al. Intra-amniotic endotoxin increases pulmonary surfactant components and induces SP-B processing in fetal sheep. Am J Physiol 2001, 280:L279.
22. Miyamura K, et al. Surfactant proteins A (SP-A) and D (SP-D)-levels in human amniotic fluid and localization in the fetal membranes. BBA-Lipid Lipid Metab 1994, 1210:303.
23. Wert SE, et al. Transcriptional elements from the human SP-C gene direct expression in the primordial respiratory epithelium of transgenic mice. Dev Biol 1993, 156:426.
24. Ross GF, et al. Surfactant protein C (SP-C) levels in fetal and ventilated preterm rabbit lungs. Am J Physiol 1999, 277:L1104.
25. Faridy EE, Thliveris JA Rate of secretion of lung surfactant before and after birth. Respir Physiol 1987, 68:269.
26. Jacobs H, et al. Accumulation of alveolar surfactant following delivery and ventilation of premature lambs. Exp Lung Res 1985, 8:125.
27. Adams FH, et al. Lung phospholipid of the human fetus and infants with and without hyaline membrane disease. J Pediatr 1970, 77:833.
28. Hallman M, et al. Effect of surfactant substitution on lung effluent phospholipids in respiratory distress syndrome: evaluation of surfactant phospholipid turnover, pool size, and the relationship to severity of respiratory failure. Pediatr Res 1986, 20:1228.
29. Griese M, et al. Pharmacokinetics of bovine surfactant in neonatal respiratory distress syndrome. Am J Respir Crit Care Med 1995, 152:1050.
30. Torresin M, et al. Exogenous surfactant kinetics in infant respiratory distress syndrome: a novel method with stable isotopes. Am J Respir Crit Care Med 2000, 161:1584.
31. Ikegami M, et al. Relationship between alveolar saturated phosphatidylcholine pool sizes and compliance of preterm rabbit lungs: the effect of maternal corticosteroid treatment. Am Rev Respir Dis 1989, 139:367.
32. Seidner S, et al. Corticosteroid potentiation of surfactant dose response in preterm rabbits. J Appl Physiol 1988, 64:2366.
33. Rebello CM, et al. Alveolar and tissue surfactant pool sizes in humans. Am J Respir Crit Care Med 1996, 154:625.
34. Jackson JC, et al. Surfactant quantity and composition during recovery from hyaline membrane disease. Pediatr Res 1986, 20:1243-1247.
35. Jackson JC, et al. Developmental changes of surface active material in newborn non-human primates. Am Rev Respir Dis 1984, 129:A204.
36. Hallman M, et al. Surfactant protein-A, phosphatidylcholine, and surfactant inhibitors in epithelial lining fluid: correlation with surface activity, severity of respiratory distress syndrome, and outcome in small premature infants. Am Rev Respir Dis 1991, 144:1376.
37. Ikegami M, Jobe AH Surfactant protein-C in ventilated premature lamb lung. Pediatr Res 1998, 44:860.
38. Seidner SR, et al. Abnormal surfactant metabolism and function in preterm ventilated baboons. Am J Respir Crit Care Med 1998, 158:1982.
39. Janssen DJ, et al. Surfactant phosphatidylcholine half-life and pool size measurements in premature baboons developing BPD. Pediatr Res 2002, 52:724.
40. Awasthi S, et al. Surfactant proteins A and D in premature baboons with chronic lung injury: evidence for an inhibition of secretion. Am J Respir Crit Care Med 1999, 160:942.
41. Weaver TE, Conkright JJ Function of surfactant proteins B and C. Annu Rev Physiol 2001, 63:555.
42. Jobe A, et al. Surfactant metabolism of newborn lamb lungs studied in vivo. J Appl Physiol 1980, 49:1091.
43. Jobe AH, et al. Saturated phosphatidylcholine secretion and the effect of natural surfactant on premature and term lambs ventilated for 2 days. Exp Lung Res 1983, 4:259.
44. Bunt JE, et al. Metabolism of endogenous surfactant in premature baboons and effect of prenatal corticosteroids. Am J Respir Crit Care Med 1999, 160:1481.
45. Bunt JE, et al. The effect in premature infants of prenatal corticosteroids on endogenous surfactant synthesis as measured with stable isotopes. Am J Respir Crit Care Med 2000, 162:844.
46. Pinkerton KE, et al. Surfactant treatment effects on lung structure and type II cells of preterm ventilated lambs. Biol Neonate 2000, 77:243.
47. Merchak A, et al. Endogenous pulmonary surfactant metabolism is not affected by mode of ventilation in premature infants with respiratory distress syndrome. J Pediatr 2002, 140:693.
48. Glatz T, et al. Metabolism of exogenously administered natural surfactant in the newborn lamb. Pediatr Res 1982, 16:711.
49. Jobe AH, et al. Surfactant phosphatidylcholine metabolism and surfactant function in preterm, ventilated lambs. Am Rev Respir Dis 1989, 139:352.
50. Ikegami M, et al. Surfactant metabolism in surfactant-treated preterm ventilated lambs. J Appl Physiol 1989, 67:429.
51. Wada K, et al. Tidal volume effects on surfactant treatment responses with the initiation of ventilation in preterm lambs. J Appl Physiol 1997, 83:1054.
52. Ikegami M, et al. Effects of ventilation style on surfactant metabolism and treatment response in preterm lambs. Am J Respir Crit Care Med 1998, 157:638.
53. Jacobs H, et al. The significance of reutilization of surfactant phosphatidylcholine. J Biol Chem 1983, 258:4156.
54. Ikegami M, et al. Surfactant protein-A metabolism in preterm ventilated lambs. Am J Physiol 1992, 262:L765.
55. Robertson D Pathology and pathophysiology of neonatal surfactant deficiency. Pulmonary Surfactant 1984, 383. Elsevier Science, Amsterdam. B. Robertson (Ed.).
56. Lachmann B, et al. Combined effects of surfactant substitution and prolongation of inspiration phase in artificially ventilated premature newborn rabbits. Pediatr Res 1982, 16:921.
57. Normand IC, et al. Passage of macromolecules between alveolar and interstitial spaces in foetal and newly ventilated lungs of the lamb. J Physiol 1970, 210:151.
58. Jobe A, et al. Permeability of premature lamb lungs to protein and the effect of surfactant on that permeability. J Appl Physiol 1983, 55:169.
59. Robertson B, et al. Leakage of protein in the immature rabbit lung; effect of surfactant replacement. Respir Physiol 1985, 61:265.
60. Jackson JC, et al. Mechanisms for reduced total lung capacity at birth and during hyaline membrane disease in premature newborn monkeys. Am Rev Respir Dis 1990, 142:413.
61. Jobe A, et al. Lung protein leaks in ventilated lambs: effects of gestational age. J Appl Physiol 1985, 58:1246.
62. Naik AS, et al. Effects of ventilation with different positive end-expiratory pressures on cytokine expression in the preterm lamb lung. Am J Respir Crit Care Med 2001, 164:494.
63. Michna J, et al. Positive end-expiratory pressure preserves surfactant function in preterm lambs. Am J Respir Crit Care Med 1999, 160:634.
64. Egan EA, et al. Fetal lung liquid absorption and alveolar epithelial solute permeability in surfactant deficient, breathing fetal lambs. Pediatr Res 1984, 18:566.
65. Pinkerton KE, et al. Lung parenchyma and type II cell morphometrics: effect of surfactant treatment on preterm ventilated lamb lungs. J Appl Physiol 1994, 77:1953.
66. Bruni R, et al. Postnatal transformations of alveolar surfactant in the rabbit: changes in pool size, pool morphology and isoforms of the 32-38 kDa apolipoprotein. Biochim Biophys Acta 1988, 958:255.
67. Jobe AH Surfactant-edema interactions. The Pathogenesis and Treatment of Pulmonary Edema 1998, 113. Futura Publishing, Armonk, NY. E.K. Weir, J.T. Reeves (Eds.).
68. Ueda T, et al. Surfactant subtypes: in vitro conversion, in vivo function, and effects of serum proteins. Am J Respir Crit Care Med 1994, 149:1254.
69. Kerr CL, et al. Effects of high-frequency oscillation on endogenous surfactant in an acute lung injury model. Am J Respir Crit Care Med 2001, 164:237.
70. Gunther A, Seeger W Resistance to surfactant inactivation. Surfactant Therapy for Lung Disease 1995, 269. Marcel Dekker, New York. B. Robertson, H.W. Taeusch (Eds.).
71. Holm BA, Enhorning G, Notter RH A biophysical mechanism by which plasma proteins inhibit lung surfactant activity. Chem Phys Lipids 1988, 49:49.
72. Ikegami M, et al. Surfactant function in the respiratory distress syndrome. J Pediatr 1983, 102:443.
73. Ikegami M, et al. A protein from airways of premature lambs that inhibits surfactant function. J Appl Physiol 1984, 57:1134.
74. Korfhagen TR, et al. Altered surfactant function and structure in SP-A gene targeted mice. Proc Natl Acad Sci USA 1996, 93:9594.
75. Cockshutt AM, et al. Pulmonary surfactant-associated protein-A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro. Biochemistry 1990, 29:8424.
76. Yukitake K, et al. Surfactant apoprotein A modifies the inhibitory effect of plasma proteins on surfactant activity in vivo. Pediatr Res 1995, 37:21.
77. Rider ED, et al. Treatment responses to surfactants containing natural surfactant proteins in preterm rabbits. Am Rev Respir Dis 1993, 147:669.
78. Seeger W, et al. Differential sensitivity to fibrinogen inhibition of SP-C-based vs SP-B-based surfactants. Am J Physiol 1992, 262:L286.
79. Hall SB, et al. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants. Am Rev Respir Dis 1992, 145:24.
80. Ikegami M, et al. Changes in exogenous surfactant in ventilated preterm lamb lungs. Am Rev Respir Dis 1993, 148:837.
81. Chen C, et al. Exogenous surfactant function in very preterm lambs with and without fetal corticosteroid treatment. J Appl Physiol 1995, 78:955.
82. Crouch EC Collectins and pulmonary host defense. Am J Respir Cell Mol Biol 1998, 19:177.
83. Jobe AH, Ikegami M Fetal responses to glucocorticoids. Endocrinology of the Lung 2000, 45-57. Humana Press, Totowa, NJ. C.R. Mendelson (Ed.).
84. van Marter LJ, et al. Rate of bronchopulmonary dysplasia as a function of neonatal intensive care practices. J Pediatr 1992, 120:938.